UNSPSC 51292009: Escitalopram

This classification denotes a selective serotonin reuptake inhibitor and antidepressant agent with the molecular formula C20H21FN2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 4O4S742ANY, chemically known as 5-isobenzofurancarbonitrile, 1-(3-(dimethylamino)propyl)-1-(4-fluorophenyl)-1,3-dihydro-, (1s)- but generally known as escitalopram, which bears US NIH Compound Identifier 146570. European Medicines Agency schedules Escitalopram in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB16425MIG.

UNSPSC 51292009 Escitalopram is a Commodity code that nominally designates a single pharmaceutical product — the selective serotonin reuptake inhibitor antidepressant escitalopram — yet the recent state and local procurement record under this code shows a significant mismatch. The single recent opportunity on file, Seminole County, Florida's IFB60459723LAS, solicits naloxone and drug deactivation systems for community health use, neither of which are escitalopram. State and local procurement activity under this code appears limited, and the tagged opportunity does not reflect the code's stated scope.

Seminole County, Florida released IFB60459723LAS on June 30, 2026 (with a due date of July 26, 2023, suggesting a data-entry anomaly in the source), seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually through competitive bidding with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida. The contract carries a two-year initial term with an option for one-year renewal, fixed-fee pricing, E-Verify compliance, drug-free workplace certification, and standard insurance requirements. The procurement does not specify set-aside designations for disadvantaged enterprises and may be funded through FEMA, introducing federal regulatory compliance obligations. No other recent opportunities under the escitalopram code are documented.